英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

thither    
a. 那边的,对面的
ad. 往那边,到那边

那边的,对面的往那边,到那边

thither
adv 1: to or toward that place; away from the speaker; "go there
around noon!" [synonym: {there}, {thither}] [ant: {here},
{hither}]

Thither \Thith"er\, adv. [OE. thider, AS. [eth]ider; akin to E.
that; cf. Icel. [thorn]a[eth]ra there, Goth.
[thorn]a[thorn]r[=o] thence. See {That}, and {The}.]
1. To that place; -- opposed to {hither}.
[1913 Webster]

This city is near; . . . O, let me escape thither.
--Gen. xix.
20.
[1913 Webster]

Where I am, thither ye can not come. --John vii.
34.
[1913 Webster]

2. To that point, end, or result; as, the argument tended
thither.
[1913 Webster]

{Hither and thither}, to this place and to that; one way and
another.
[1913 Webster]

Syn: There.

Usage: {Thither}, {There}. Thither properly denotes motion
toward a place; there denotes rest in a place; as, I
am going thither, and shall meet you there. But
thither has now become obsolete, except in poetry, or
a style purposely conformed to the past, and there is
now used in both senses; as, I shall go there
to-morrow; we shall go there together.
[1913 Webster]


Thither \Thith"er\, a.
1. Being on the farther side from the person speaking;
farther; -- a correlative of hither; as, on the thither
side of the water. --W. D. Howells.
[1913 Webster]

2. Applied to time: On the thither side of, older than; of
more years than. See {Hither}, a. --Huxley.
[1913 Webster]


请选择你想看的字典辞典:
单词字典翻译
thither查看 thither 在百度字典中的解释百度英翻中〔查看〕
thither查看 thither 在Google字典中的解释Google英翻中〔查看〕
thither查看 thither 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Huntingtons Disease (HD) Chorea Treatment - AUSTEDO XR®
    The most common side effects of AUSTEDO XR are expected to be similar to AUSTEDO in people with Huntington’s disease or tardive dyskinesia These are not all the possible side effects of AUSTEDO XR or AUSTEDO Call your doctor for medical advice about side effects You are encouraged to report side effects of prescription drugs to the FDA
  • Austedo Austedo XR: Uses, Side Effects, Dosage Guide
    Huntington's disease chorea is sudden involuntary movements usually of the arms, legs, face, and tongue It is an inherited disease that causes the progressive breakdown of nerve cells in the brain Deutetrabenazine is not a cure for Huntington's disease and will not treat other symptoms of this condition How does Austedo work?
  • AUSTEDO XR AUSTEDO DOSAGE FORMS AND STRENGTHS
    • AUSTEDO XR and AUSTEDO are contraindicated in patients who are suicidal, and in patients with untreated or inadequately treated depression (4, 5 1) INDICATIONS AND USAGE AUSTEDO XR and AUSTEDO are vesicular monoamine transporter 2 (VMAT2) inhibitors indicated in adults for the treatment of: • Chorea associated with Huntington’s
  • Austedo: Huntingtons Disease Uses, Side Effects, Dosage
    Austedo is a prescription medication that is used to treat the involuntary movements (chorea) of Huntington's disease The most common side effects of Austedo in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia) Austedo can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients
  • Austedo (deutetrabenazine) for Huntington’s disease . . .
    There was also a dose-proportional exposure to Austedo XR in the blood for all pharmacokinetics parameters and over the recommended dose range (6-48 mg) Common side effects of Austedo The most common side effects associated with Austedo and Austedo XR in Huntington’s include: somnolence or sleepiness; diarrhea; dry mouth; fatigue
  • AUSTEDO® XR: Tardive Dyskinesia and Huntingtons Chorea Treatment
    AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington's disease chorea See safety info including Boxed Warning Teva Shared Solutions® 1-800-887-8100
  • Clinical Policy: Deutetrabenazine (Austedo, Austedo XR)
    Deutetrabenazine (Austedo ®, Austedo ® XR) is a vesicular monoamine transporter 2 (VMAT2) inhibitor FDA Approved Indication(s) Austedo and Austedo XR are indicated for the treatment of: • Chorea associated with Huntington’s disease • Tardive dyskinesia (TD) in adults Policy Criteria
  • Austedo (Deutetrabenazine) - Rare Disease Advisor
    Austedo ® (deutetrabenazine) and Austedo XR are oral vesicular monoamine transporter 2 (VMAT2) inhibitors that are indicated for the treatment of chorea associated with Huntington disease (HD) in adults 1 Austedo was developed by Teva and approved by the US Food and Drug Administration (FDA) in 2017
  • Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine . . .
    AUSTEDO XR AUSTEDO is the first and only vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U S Food and Drug Administration in adults for the treatment of tardive dyskinesia (TD) and for the treatment of chorea associated with Huntington’s disease (HD) AUSTEDO XR is the once-daily formulation of AUSTEDO
  • Approved Treatments for Huntingtons Disease
    Austedo and Austedo XR Available in tablets, the medications are taken orally once or twice daily, depending on the formulation Their active ingredient is similar to that of Xenazine, an older approved treatment for Huntington’s chorea, but it is designed to last longer in the body
  • Huntington’s Disease (HD) Chorea | AUSTEDO XR . . .
    Voiceover Onscreen text: INDICATIONS AND USAGE AUSTEDO® XR (deutetrabenazine) extended-release tablets and AUSTEDO® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and for the treatment of tardive dyskinesia
  • Deutetrabenazine: Uses, Dosage, Side Effects . . . - Drugs. com
    Deutetrabenazine FDA approval for treatment of chorea associated with Huntington’s disease was granted on April 3, 2017, based on positive results from deutetrabenazine clinical trials, the Phase III randomized, placebo-controlled study called First-HD Total Maximal Chorea Scores were averaged over the maintenance period (week 9 to week 12)





中文字典-英文字典  2005-2009